Showing results (151-160 of 226) with videos related to
Sort By:
Pageof 23
Schizophrenia Bulletin|April 2, 2009
Amygdalofrontal functional disconnectivity and aggression in schizophreniaMatthew J Hoptman, Debra D'Angelo, Dean Catalano, et al.Nucleic Acids Research|September 28, 2020
Elements at the 5' end of Xist harbor SPEN-independent transcriptional antiterminator activityJackson B Trotman, David M Lee, Rachel E Cherney, et al.Leukemia|April 17, 2023
Health-related quality of life of patients with resistant/intolerant chronic phase chronic myeloid leukemia treated with asciminib or bosutinib in the phase 3 ASCEMBL trialDelphine Réa, Carla Boquimpani, Michael J Mauro, et al.Blood|February 10, 2006
BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate-treated patients with CMLRichard D Press, Zac Love, Ashlie A Tronnes, et al.Cell Reports|July 12, 2023
Proximity-dependent recruitment of Polycomb repressive complexes by the lncRNA AirnAki K Braceros, Megan D Schertzer, Arina Omer, et al.Blood|July 2, 2002
Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experienceRita M Braziel, Teresa M Launder, Brian J Druker, et al.Clinical Lymphoma, Myeloma & Leukemia|March 20, 2016
Evaluating the Impact of a Switch to Nilotinib on Imatinib-Related Chronic Low-Grade Adverse Events in Patients With CML-CP: The ENRICH StudyJorge E Cortes, Jeffrey H Lipton, Carole B Miller, et al.Leukemia|March 21, 2003
Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylateM E O'Dwyer, K M Gatter, M Loriaux, et al.RNA (New York, N.Y.)|July 19, 2023
SAFB associates with nascent RNAs and can promote gene expression in mouse embryonic stem cellsRachel E Cherney, Quinn E Eberhard, Gilbert Giri, et al.Health Physics|August 24, 1999
Sites in the United States contaminated with radioactivityA B Wolbarst, P F Blom, D Chan, et al.Pageof 23